Machine learning can help accurately predict clinical outcomes in patients with heart problems

Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes in patients with known or potential heart problems. Collectively, the findings suggest that machine learning may usher in a new era in digital health care tools capable of enhancing health care delivery by aiding routine processes and helping physicians assess patients' risk.

While clinical scoring systems and algorithms have long been used in medical practice, there has been a marked uptick in the application of machine learning to improve such tools in recent years. In contrast to traditional algorithms that require all calculations to be pre-programmed, machine learning algorithms deduce the optimal set of calculations by looking for patterns in large collections of patient data.

The new studies presented at ACC.18 demonstrate how machine learning can be used to predict outcomes such as diagnosis, death or hospital readmission; improve upon standard risk assessment tools; elucidate factors that contribute to disease progression; or to advance personalized medicine by predicting a patient's response to treatment.

In one study, researchers used machine learning to predict which patients would ultimately be diagnosed with a heart attack after coming to a hospital emergency department for chest pain. Chest pain is one of the most common complaints among patients visiting the emergency department, yet only a minority of these patients are ultimately diagnosed with a heart attack. In a pilot test, the algorithm showed a 94 percent accuracy rate for predicting the ultimate diagnosis.

"The long-term goal is to identify those who are at highest risk and to treat those patients first," said Daniel Lindholm, MD, PhD, postdoctoral research fellow at Uppsala University in Sweden and the study's lead author. "If this work is further validated, hospitals could potentially use it to quickly pick out which patients are sickest when they arrive at the hospital, and that could lead to a shorter time to treatment for those who need it most."

Lindholm and his colleague developed and tested their algorithm using data from more than 8,200 emergency department visits in Stockholm between 2011 and 2013. In the first (training) phase, the algorithm used data from 5,800 patient visits to iteratively refine decision trees to identify a heart attack diagnosis based on factors such as blood test results, vital signs and the patient's medical history--the same data that a physician would have upon first encountering a patient.

In the second (validation) phase, the algorithm uses the same types of patient data from a separate set of 2,400 visits, including blood test results, vital signs and medical history, but information about ultimate heart attack diagnosis was excluded to test how accurately the algorithm could predict which patients were ultimately diagnosed with a heart attack.

Overall, the algorithm was able to accurately predict a heart attack diagnosis 94 percent of the time in the validation data set. Ninety percent is generally considered a high rate of accuracy for models of this type. Researchers also ran the validation data through a standard clinical model (the hsTnT model, which incorporates only a patient's age, sex and high-sensitivity troponin levels), which showed an accuracy of 88 percent. The results suggest the machine learning approach could offer a substantial improvement over current decision support tools.

"In a broad sense, machine learning methods have been around for quite some time, but it's just in the last few years that we have gained the large data sets and computational capabilities to use them for clinical applications," Lindholm said. "I think that we will see more and more decision support systems based on machine learning. But even as machine learning can enhance medical practice, I do not think these algorithms will ultimately replace physicians but, rather, provide decision support based on the data at hand. Other things, such as empathy, human judgment and the patient-doctor relationship are crucial."

To bring their algorithm closer to clinical application, Lindholm said the research team will first need to evaluate it in larger data sets that include more hospitals in diverse environments and then validate it in a prospective clinical study.

Lindholm will present the study, "Machine Learning for Improved Detection of Myocardial Infarction in Patients Presenting with Chest Pain in the Emergency Department," on Monday, March 11 at 9:45 a.m. ET in Poster Hall A/B.

Other studies involving the application of machine learning being presented at ACC.18 include the following:

  • "A Highly Predictive Machine Learning Model to Identify Hospitalized Patients at Risk for 30-Day Readmission or Mortality"
  • "Machine Learning in Predicting Coronary Heart Disease and Cardiovascular Disease Events: Results from the Multi-ethnic Study of Atherosclerosis (mesa)"
  • "A Novel Ensemble Machine Learning-Based Method versus Clinical Risk Scoring for Discrimination of Individuals Who Will versus Will Not Experience Acute Coronary Syndrome After Coronary Computed Tomographic Angiography: Results from the ICONIC Study"
  • "Machine Learning Models Significant Improve Outcome Prediction after Cardiac Arrest"
  • "Prediction of In-Hospital Mortality and Length of Stay in Acute Coronary Syndrome Patients Using Machine-learning Methods"
  • "Machine Learning Models to Predict In-hospital Mortality for ST-Elevation Myocardial Infarction: From China Acute Myocardial Infarction (CAMI) Registry"
  • "Frailty and Cardiovascular Surgery, Deep Neural Network Versus Support Vector Machine to Predict Death"
  • "Development of High Sensitivity Screening for Assessing Individual Level Risk for Peripheral Arterial Disease"
  • "The Risk in Treating Estimated Risk: An Algorithm for Calculating Confidence Intervals for Risk Prediction Equations"
  • "The Use of Machine Learning to Predict Doxorubicin Cardiotoxicity"
  • "A Machine Learning Model Predicts Individuals Who Improve Coronary Artery Plaque Fibrous Cap Thickness Following High-Intensity Statin Therapy."

Related ACC.18 Event: ACC is partnering with angelMD to host the ACC.18 Innovation Challenge, a shark-tank style competition, which will feature startups from around the country, pitching products and services in two categories: digital health and medical devices. Out of 60 applications, four finalists have been selected in each category to present their innovation. In the end, two winners will be awarded an opportunity to take their vision to the next level. The audience will also have the opportunity to vote and be part of the selection process. Stop by the ACC.18 Future Hub on Sunday, March 11 from 9:45 a.m. - 10:45 a.m. to hear pitches on digital health and 3:45 p.m. - 4:45 p.m. to hear the pitches on medical devices.

Advertisement

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Biomarker blood test does not appear to curb antibiotic overuse, shows new study